Improvement of Laboratory Diagnostics in Hypothyroid Patients Using Levothyroxine
NCT06083636 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2025-10-03
Summary
Hypothyroidism is a thyroid disorder and one of the most common endocrine disorders. Hypothyroidism can have multiple causes; most patients suffer from primary autoimmune hypothyroidism (Hashimoto's disease), but also central hypothyroidism, hypothyroidism after total thyroidectomy due to thyroid carcinoma, or hypothyroidism due to therapy of Graves' disease occur. Most patients with hypothyroidism are treated with levothyroxine (L-T4) to supplement the lack of thyroxine (T4) produced by their own thyroid. Serum thyroid-stimulating hormone (TSH) and/or free T4 (fT4) are currently measured to assess the efficacy of this therapy and to establish euthyroidism. It is known that fT4 concentrations in patients using L-T4 can be above the upper limit of the reference interval, while their TSH is not (completely) suppressed. This raises the question whether fT4 is an accurate reflection of thyroid hormone status in patients using L-T4. TSH is considered a reliable parameter of thyroid hormone status; however, TSH cannot be used to assess thyroid function in specific hypothyroid patient groups (e.g. central hypothyroidism). Free triiodothyronine (fT3), the active thyroid hormone, has been suggested to be an interesting alternative of fT4 to assess thyroid function. Previously, the methods to measure fT3 were not that robust; however, methods to determine fT3 have been improved, are currently reliable and not susceptible to changes due to L-T4 intake. In addition, the fT3/fT4 ratio is thought to be an interesting candidate in assessing thyroid hormone status as well. The aim of this study is to improve laboratory diagnostics of thyroid hormone status in patients with hypothyroidism receiving L-T4 in whom TSH cannot be used as a reflection of thyroid hormone status. We will primarily investigate the additional already available laboratory tests fT3 and fT3/fT4 ratio. We hypothesize that treated hypothyroid participants who are assumed euthyroid based on TSH (e.g. patients with Hashimoto's hypothyroidism) but have fT4 concentrations above the upper reference limit will more often have a fT3 level or a fT3/fT4 ratio within the reference interval. Concentrations of alternative markers in healthy controls and patients with Hashimoto's hypothyroidism with 'normal' TSH concentrations can, thus, be used to predict thyroid hormone status in patients using L-T4 in whom TSH cannot be used to assess thyroid hormone status.
Conditions
Interventions
- OTHER
-
Single extra blood draw and completion of single questionnaire
Single blood draw of 3 tubes (20 mL) additional to regular blood draw will be performed. All participants will complete a single questionnaire that will be 5-10 minutes time-consuming.
- OTHER
-
Single blood draw and completion of single questionnaire
Single blood draw of 3 tubes (20 mL) will be performed. All participants will complete a single questionnaire that will be 5-10 minutes time-consuming.
Sponsors & Collaborators
-
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
lead OTHER
Principal Investigators
-
Annemieke C Heijboer, Prof. dr. · Amsterdam UMC, VU Amsterdam and UvA, Endocrine Laboratory, Department of Laboratory Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-26
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- Netherlands
Study Locations
More Related Trials
-
Metabolomics of Thyroid Hormones
NCT03823859 ·Status: COMPLETED
-
Thyroid Hormone Replacement After Radio Iodine: Value and Efficacy
NCT06647602 ·Status: NOT_YET_RECRUITING
-
Thyroid Replacement Therapy in Patients With Subclinical Hypothyroidism
NCT04953195 ·Status: UNKNOWN ·Phase: PHASE4
-
An Assessment of the Occurrence of Hypothyroidism in Patients Treated With RAI for Hyperthyroidism.
NCT04663451 ·Status: UNKNOWN
-
Quality of Life and Long-term Outcome of Adequately Treated Congenital Hypothyroidism
NCT06864039 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Insulin Sensitivity and Metabolism Before and After Treatment in Patients With Hypothyroidism
NCT00770016 ·Status: TERMINATED ·Phase: NA
-
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
NCT01916304 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Thyroid Hormone Enzyme Blocking on Hypothyroidism
NCT01801033 ·Status: WITHDRAWN
-
Is Levothyroxine Alone Adequate Thyroid Hormone Replacement?
NCT02567877 ·Status: TERMINATED
-
Thyroxine Therapy for Recurrent Pregnancy Loss in Hypothyroid Women
NCT06036576 ·Status: COMPLETED ·Phase: PHASE3
-
Hypothyroidism, Metabolism and Quality of Life - Focus on QOL, REE, Cognitive Function and Body Composition
NCT02891668 ·Status: COMPLETED
-
Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
NCT01848171 ·Status: UNKNOWN ·Phase: PHASE4
-
Subclinical Hypothyroidism and Mind in the Elderly
NCT00921050 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hypothyroidism, Metabolism and Food Intake
NCT02993562 ·Status: COMPLETED
-
LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients with Autoimmune Hypothyroidism.
NCT05682482 ·Status: RECRUITING ·Phase: PHASE3
-
Mean Percentage of Levothyroxine Dosage Increase in Patients With Hypothyroidism Started on Enteral Feeding
NCT02577367 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Thyroid Hormone Replacement on Fatigability in Untreated Older Adults With Subclinical Hypothyroidism
NCT02500342 ·Status: COMPLETED ·Phase: PHASE4
-
Recurrent Pregnancy Loss and Thyroid Disease
NCT03106935 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Long-Term Efficacy and Safety of Once-Weekly Levothyroxine Regimen in Hypothyroid Patients
NCT07133295 ·Status: COMPLETED
-
Mechanistic Study of Subclinical Hypothyroidism In the Elderly
NCT02399475 ·Status: COMPLETED ·Phase: NA
-
Levothyroxine Treatment and IVF Outcomes in Women With Subclinical Hypothyroidism: A Target Trial Emulation
NCT07257250 ·Status: RECRUITING
-
Patient-centered Dosage of Levothyroxine
NCT06455371 ·Status: RECRUITING ·Phase: NA
-
Dosing of LT4 in Older Individuals
NCT06073665 ·Status: RECRUITING ·Phase: PHASE4
-
Thyroid Profiles in Patients With Acute Illness
NCT05980923 ·Status: WITHDRAWN
-
Thyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)
NCT03096613 ·Status: UNKNOWN ·Phase: PHASE4